<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rehab</journal-id><journal-title-group><journal-title xml:lang="ru">Реабилитология</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Medical Rehabilitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-5873</issn><issn pub-type="epub">2949-5881</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2949-5873/rehabil.2024.21</article-id><article-id custom-type="elpub" pub-id-type="custom">rehab-11</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>Маршрутизация пациенток при реабилитации после лечения онкогинекологических патологий</article-title><trans-title-group xml:lang="en"><trans-title>Patient routing system in rehabilitation after treatment for oncogynecological pathologies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-2166-2574</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акавова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Akavova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Акавова Саида Абдулкадыровна</p><p>Загородное ш., д. 18А, стр. 7, Москва 117152</p></bio><bio xml:lang="en"><p>Saida A. Akavova</p><p>18А bldg 7 Zagorodnoe Shosse, Moscow 117152</p></bio><email xlink:type="simple">saida_akavova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения г. Москвы «Городская клиническая онкологическая больница № 1 Департамента здравоохранения г. Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Clinical Oncology Hospital No. 1</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>06</day><month>09</month><year>2024</year></pub-date><volume>2</volume><issue>1</issue><fpage>158</fpage><lpage>172</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Акавова С.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Акавова С.А.</copyright-holder><copyright-holder xml:lang="en">Akavova S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rehabilitology.com/jour/article/view/11">https://www.rehabilitology.com/jour/article/view/11</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. В последние годы онкогинекологические заболевания у женщин репродуктивного возраста диагностируются все чаще. Несмотря на высокую эффективность лечения, в системе реабилитации таких пациенток отмечаются значительные недостатки.</p></sec><sec><title>Цель</title><p>Цель: представить преемственность и особенности системы реабилитации у пациенток онкогинекологического профиля.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В обзор вошло 75 публикаций из авторитетных источников, соответствующих теме и представляющих уникальные выводы. Поиск статей проведен в отечественных и иностранных онлайн-библиотеках, базах данных и поисковых системах. Поиск и скрининг осуществлены в соответствии с рекомендациями PRISMA.</p></sec><sec><title>Результаты</title><p>Результаты. Пациенткам с онкогинекологическими заболеваниями необходимо уделять особое внимание при оказании медицинской помощи на восстановительном этапе. Важно соблюдать принцип преемственности между всеми этапами системы реабилитации – сразу после проведения лечения, в отделении реабилитации и амбулаторно. Данная система разработана в России, однако требует масштабирования и решения целого ряда проблем – от недостатка врачей-реабилитологов, ограниченности применения перспективных методов реабилитации до неполной психологической поддержки и отсутствия общепринятой системы комплексной реабилитации. При этом для оказания узкоспециализированной помощи существует достаточно много как традиционных, так и высокотехнологичных инструментов.</p></sec><sec><title>Заключение</title><p>Заключение. Агрессивное лечение онкогинекологических заболеваний пагубно влияет на общее самочувствие женщины, значительно снижая качество жизни. Ранее реабилитационную помощь сильно затрудняла закостенелость системы как на методическом, так и на административном уровне. В последнее время произошли положительные сдвиги в решении проблем оказания помощи пациенткам онкогинекологического профиля, однако для качественного изменения ситуации представленных мер недостаточно.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. In recent years, oncogynecological diseases have been diagnosed more frequently in women of reproductive age. Despite the high efficiency of treatment measures, significant shortcomings in the rehabilitation system for such patients are noted.</p></sec><sec><title>Objective</title><p>Objective: to present the continuity and features of the rehabilitation system for patients of oncogynecological profile.</p></sec><sec><title>Material and methods</title><p>Material and methods. This review included 75 relevant publications from authoritative sources that presented unique findings. The search was conducted in Russian and foreign online libraries, databases and search engines. PRISMA recommendations were used for search and screening.</p></sec><sec><title>Results</title><p>Results. Oncogynecological patients need special attention in providing them medical care at the recovery stage. It is important to adhere to the principle of continuity between all steps of rehabilitation system: immediately after treatment, in rehabilitation department, and on outpatient stage. This system has been developed in Russia, but it needs scaling and solving a number of problems, ranging from a shortage of rehabilitation doctors, limited use of promising rehabilitation tools to insufficient provision of psychological assistance and the absence of generally accepted comprehensive rehabilitation system. At the same time, there is sufficient set of traditional and high-tech rehabilitation methods to provide highly specialized care.</p></sec><sec><title>Conclusion</title><p>Conclusion. Aggressive treatment of oncogynecological diseases has a detrimental effect on the general well-being of women, significantly reducing their quality of life. Previously, proper provision of rehabilitation care encountered the rigidity of the system both at methodological and administrative levels. Recently, there have been positive shifts in solving problems of providing care to oncogynecological patients, however, the presented measures are not enough to qualitatively change the situation.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>реабилитация</kwd><kwd>онкология</kwd><kwd>гинекология</kwd><kwd>рак шейки матки</kwd><kwd>РШМ</kwd><kwd>система реабилитации</kwd><kwd>маршрутизация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rehabilitation</kwd><kwd>oncology</kwd><kwd>gynecology</kwd><kwd>cervical cancer</kwd><kwd>rehabilitation system</kwd><kwd>routing</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021; 18 (10): 663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation><mixed-citation xml:lang="en">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021; 18 (10): 663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209–49. https://doi.org/10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209–49. https://doi.org/10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шахзадова А.О., Старинский В.В., Лисичникова И.В. Состояние онкологической помощи населению России в 2022 году. Сибирский онкологический журнал. 2023; 22 (5): 5–13. https://doi.org/10.21294/1814-4861-2023-22-5-5-13.</mixed-citation><mixed-citation xml:lang="en">Shakhzadova A.O., Starinsky V.V., Lisichnikova I.V. Cancer care to the population of Russia in 2022. Siberian Journal of Oncology. 2023; 22 (5): 5–13 (in Russ.). https://doi.org/10.21294/1814-4861-2023-22-5-5-13.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Заболеваемость раком шейки матки, на 100 000 населения. Всемирная организация здравоохранения. Европейский портал информации здравоохранения. URL: https://gateway.euro.who.int/ru/indicators/hfa_377-2360-incidence-of-cervix-uteri-cancerper-100-000/ (дата обращения 03.12.2023).</mixed-citation><mixed-citation xml:lang="en">Incidence of cervix uteri cancer per 100 000. The World Health Organization. European Health Information Gateway. Available at: https://gateway.euro.who.int/en/indicators/hfa_377-2360-incidenceof-cervix-uteri-cancer-per-100-000/#id=19308 (accessed 03.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Блинов Д.В., Солопова А.Г., Плутницкий А.Н. и др. Организация здравоохранения в сфере реабилитации пациенток с онкологическими заболеваниями репродуктивной системы. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022; 15 (1): 119–30. https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132.</mixed-citation><mixed-citation xml:lang="en">Blinov D.V., Solopova A.G., Plutnitskiy A.N., et al. Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022; 15 (1): 119–30 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Департамента здравоохранения города Москвы от 11.09.2020 № 1032 «О диспансерном наблюдении за взрослыми со злокачественными новообразованиями и пациентами с заболеваниями из групп риска по развитию злокачественных новообразований». URL: https://docs.cntd.ru/document/603188178 (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Order of the Department of Health of the Moscow city dated 11.09.2020 No. 1032 “On dispensary supervision of adults with malignant neoplasms and patients with diseases from risk groups for the development of malignant neoplasms”. Available at: https://docs.cntd.ru/document/603188178 (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Департамента здравоохранения города Москвы от 14.01.2022 № 16 «Об организации оказания медицинской помощи по профилю «онкология» в медицинских организациях государственной системы здравоохранения города Москвы». URL: https://docs.cntd.ru/document/728352117 (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Order of the Department of Health of the Moscow city dated 14.01.2022 No. 16 “On the organization of medical care in the ﬁeld of oncology in medical organizations of the state healthcare system of the Moscow city”. Available at: https://docs.cntd.ru/document/728352117 (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Рак шейки матки. Клинические рекомендации. 2020. URL: https://cr.minzdrav.gov.ru/recomend/537_1 (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Cervical cancer. Clinical guidelines. 2020. Available at: https://cr.minzdrav.gov.ru/recomend/537_1 (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatla N., Berek J.S., Cuello Fredes M., et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019; 145 (1): 129–35. https://doi.org/10.1002/ijgo.12749.</mixed-citation><mixed-citation xml:lang="en">Bhatla N., Berek J.S., Cuello Fredes M., et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019; 145 (1): 129–35. https://doi.org/10.1002/ijgo.12749.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Goldstraw P., Chansky K., Crowley J., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classiﬁcation for lung cancer. J Thorac Oncol. 2016; 11 (1): 39–51. https://doi.org/10.1016/j.jtho.2015.09.009.</mixed-citation><mixed-citation xml:lang="en">Goldstraw P., Chansky K., Crowley J., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classiﬁcation for lung cancer. J Thorac Oncol. 2016; 11 (1): 39–51. https://doi.org/10.1016/j.jtho.2015.09.009.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Чернышова А.Л., Коломиец Л.А., Красильников С.Э. Органосохраняющее лечение при инвазивном раке шейки матки. Сибирский онкологический журнал. 2011; 2: 72–8.</mixed-citation><mixed-citation xml:lang="en">Chernyshova A.L., Kolomiets L.A., Krasilnikov S.E. Organ-preserving surgery for patients with invasive uterine cervix cancer. Siberian Journal of Oncology. 2011; 2: 72–8 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Балахонцева О.С., Новикова О.В., Антипов В.А. Гормонотерапия сопровождения при освоении методики радикальной абдоминальной трахелэктомии. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2009; 20 (2): 60.</mixed-citation><mixed-citation xml:lang="en">Balakhontseva O.S., Novikova O.V., Antipov V.A. Hormone therapy support in mastering the technique of radical abdominal trachelectomy. Bulletin of Blokhin Russian Cancer Research Center. 2009; 20 (2): 60 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Тумунов Ч.Б., Бадмажапов А.В., Насанов Н.Б., Каюкова Е.В. Оценка эффективности использования радикальной трахелэктомии в лечении рака шейки матки. В кн.: Медицина завтрашнего дня. Материалы XVI межрегиональной научно-практической конференции студентов и молодых ученых: сборник научных трудов. Чита: Читинская государственная медицинская академия; 2017: 170–1.</mixed-citation><mixed-citation xml:lang="en">Tumunov Ch.B., Badmazhapov A.V., Nasonov N.B., Kayukova E.V. Evaluation of the eﬀectiveness of radical trachelectomy in the treatment of cervical cancer. In: The medicine of tomorrow. Materials of the 16th interregional scientiﬁc and practical conference of students and young scientists: collection of scientiﬁc papers. Chita: Chita State Medical Academy; 2017: 170–1 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Кайрбаев М.Р., Кайрбаева М.Ж., Сериков С.М., Сарсенова А.Б. Отдаленные результаты радикальной трахелэктомии при инвазивном раке шейки матки у женщин фертильного возраста. Онкология и радиология Казахстана. 2019; S: 74–5.</mixed-citation><mixed-citation xml:lang="en">Kairbaev M.R., Kairbayeva M.Zh., Serikov S.M., Sarsenova A.B. Long-term results of radical trachelectomy for invasive cervical cancer in women of fertile age. Oncology and Radiology of Kazakhstan. 2019; S: 74–5 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Оводенко Д.Л., Хабас Г.Н., Макарова А.С. и др. Лапароскопическая радикальная гистерэктомия при раке шейки матки стадий Ia2–IIb. Акушерство и гинекология. 2018; 4: 101–7. https://doi.org/10.18565/aig.2018.4.101-107.</mixed-citation><mixed-citation xml:lang="en">Ovodenko D.L., Khabas G.N., Makarova A.S., et al. Laparoscopic radical hysterectomy for stage Ia2–Ib cervical cancer. Obstetrics and Gynecology. 2018; 4: 101–7 (in Russ.). https://doi.org/10.18565/aig.2018.4.101-107.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the eﬀects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008; 26 (35): 5802–12. https://doi.org/10.1200/JCO.2008.16.4368.</mixed-citation><mixed-citation xml:lang="en">Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the eﬀects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008; 26 (35): 5802–12. https://doi.org/10.1200/JCO.2008.16.4368.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Оводенко Д.Л., Хабас Г.Н., Макарова А.С. и др. Современные методы лечения больных местнораспространенным раком шейки матки. Акушерство и гинекология: новости, мнения, обучение. 2019; 7 (1): 68–74.</mixed-citation><mixed-citation xml:lang="en">Ovodenko D.L., Khabas G.N., Makarova A.S., et al. Modern terapeutic intervention for patients with regional cervical cancer. Obstetrics and Gynecology: News, Opinions, Training. 2019; 7 (1): 68–74 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Okunade K.S. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020; 40 (5): 602–8. https://doi.org/10.1080/01443615.2019.1634030.</mixed-citation><mixed-citation xml:lang="en">Okunade K.S. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020; 40 (5): 602–8. https://doi.org/10.1080/01443615.2019.1634030.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Q., Wang J., Sun Y., et al. Eﬃcacy and safety of sintilimab plus anlotinib for PD-L1-positive recurrent or metastatic cervical cancer: a multicenter, single-arm, prospective phase II trial. J Clin Oncol. 2022; 40 (16): 1795–805. https://doi.org/10.1200/JCO.21.02091.</mixed-citation><mixed-citation xml:lang="en">Xu Q., Wang J., Sun Y., et al. Eﬃcacy and safety of sintilimab plus anlotinib for PD-L1-positive recurrent or metastatic cervical cancer: a multicenter, single-arm, prospective phase II trial. J Clin Oncol. 2022; 40 (16): 1795–805. https://doi.org/10.1200/JCO.21.02091.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Shibata T., Lieblong B.J., Sasagawa T., Nakagawa M. The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer. Cancer Treat Rev. 2019; 78: 8–16. https://doi.org/10.1016/j.ctrv.2019.07.001.</mixed-citation><mixed-citation xml:lang="en">Shibata T., Lieblong B.J., Sasagawa T., Nakagawa M. The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer. Cancer Treat Rev. 2019; 78: 8–16. https://doi.org/10.1016/j.ctrv.2019.07.001.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Silva A.J.D., de Moura I.A., da Gama M.A.T.M., et al. Advancing immunotherapies for HPV-related cancers: exploring novel vaccine strategies and the inﬂuence of tumor microenvironment. Vaccines. 2023; 11 (8): 1354. https://doi.org/10.3390/vaccines11081354.</mixed-citation><mixed-citation xml:lang="en">Silva A.J.D., de Moura I.A., da Gama M.A.T.M., et al. Advancing immunotherapies for HPV-related cancers: exploring novel vaccine strategies and the inﬂuence of tumor microenvironment. Vaccines. 2023; 11 (8): 1354. https://doi.org/10.3390/vaccines11081354.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bonneville R., Krook M.A., Kautto E.A., et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017; 2017: PO.17.00073. https://doi.org/10.1200/PO.17.00073.</mixed-citation><mixed-citation xml:lang="en">Bonneville R., Krook M.A., Kautto E.A., et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017; 2017: PO.17.00073. https://doi.org/10.1200/PO.17.00073.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tewari K.S., Sill M.W., Penson R.T., et al. Bevacizumab for advanced cervical cancer: ﬁnal overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017; 390 (10103): 1654–63. https://doi.org/10.1016/S0140-6736(17)31607-0.</mixed-citation><mixed-citation xml:lang="en">Tewari K.S., Sill M.W., Penson R.T., et al. Bevacizumab for advanced cervical cancer: ﬁnal overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017; 390 (10103): 1654–63. https://doi.org/10.1016/S0140-6736(17)31607-0.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Чуруксаева О.Н., Коломиец Л.А. Проблемы качества жизни онкогинекологических больных. Вопросы oнкологии. 2017; 63 (3): 368–74.</mixed-citation><mixed-citation xml:lang="en">Churuksaeva O.N., Kolomiets L.A. Quality of life problems of gynecological cancer patients. Voprosy onkologii / Problems in Oncology. 2017; 63 (3): 368–74 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Идрисова Л.Э., Макацария А.Д. и др. Мультидисциплинарный подход к медицинской реабилитации онкогинекологических больных. Акушерство, гинекология и репродукция. 2017; 11 (4): 57–67. https://doi.org/10.17749/2313-7347.2017.11.4.057-067.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Idrisova L.E., Makatsariya A.D., et al. Multidisciplinary approach to medical rehabilitation of oncogynecologic patients. Obstetrics, Gynecology and Reproduction. 2017; 11 (4): 57–67 (in Russ.). https://doi.org/10.17749/2313-7347.2017.11.4.057-067.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Молчанов С.В., Коломиец Л.А., Гриднева Т.Д. Роль реабилитации в повышении качества жизни онкогинекологических больных репродуктивного возраста после противоопухолевого лечения. Сибирский онкологический журнал. 2012; 3: 46–9.</mixed-citation><mixed-citation xml:lang="en">Molchanov S.V., Kolomiets L.A., Gridneva T.D. Role of rehabilitation in life quality improvment for cancer patients of reproductive age after antitumor treatment. Siberian Journal of Oncology. 2012; 3: 46–9.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Hu H., Fu M., Huang X., et al. Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis. Transl Cancer Res. 2022; 11 (6): 1713–21. https://doi.org/10.21037/tcr-22-1256.</mixed-citation><mixed-citation xml:lang="en">Hu H., Fu M., Huang X., et al. Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis. Transl Cancer Res. 2022; 11 (6): 1713–21. https://doi.org/10.21037/tcr-22-1256.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Корытов О.В. Влияние поздних лучевых осложнений на качество жизни и отдаленную выживаемость пациентов, получавших облучение органов малого таза. Российский биотерапевтический журнал. 2022; 21 (2): 67–72. https://doi.org/10.17650/1726-9784-2022-21-2-67-72.</mixed-citation><mixed-citation xml:lang="en">Korytov O.V. Inﬂuence of late radiation complications on long-term survival of patients treated with irradiation of the pelvic organs. Russian Journal of Biotherapy. 2022; 21 (2): 67–72 (in Russ.). https://doi.org/10.17650/1726-9784-2022-21-2-67-72.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Столярова И.В., Винокуров Л.В. Проблемы больных после лечения рака шейки матки (профилактика и лечение постлучевых осложнений). Практическая oнкология. 2002; 3 (3): 220–7.</mixed-citation><mixed-citation xml:lang="en">Stolyarova I.V., Vinokurov L.V. Problems of patients after treatment for cervical cancer (prevention and treatment of post-radiation complications). Practical Oncology. 2002; 3 (3): 220–7.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Сычева И.В., Каприн А.Д., Иванов С.А. Сочетание поздних лучевых повреждений органов малого таза у больной после химиолучевого лечения рака шейки матки IIB ст. cT2bN0M0 и их лечение (клинический пример). Вопросы oнкологии. 2022; 68 (1): 99–105. https://doi.org/10.37469/0507-3758-2022-68-1-99-105.</mixed-citation><mixed-citation xml:lang="en">Sycheva I.V., Kaprin A.D., Ivanov S.A. The combination of late radiation injuries of the pelvic organs in a patient after chemoradiotherapy of cervical cancer II b (cT2bN0M0) and their treatment (clinical example). Voprosy onkologii / Problems in Oncology. 2022; 68 (1): 99–105 (in Russ.). https://doi.org/10.37469/0507-3758-2022-68-1-99-105.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Mishra N., Singh N., Sachdeva M., Ghatage P. Sexual dysfunction in cervical cancer survivors: a scoping review. Womens Health Rep. 2021; 2 (1): 594–607. https://doi.org/10.1089/whr.2021.0035.</mixed-citation><mixed-citation xml:lang="en">Mishra N., Singh N., Sachdeva M., Ghatage P. Sexual dysfunction in cervical cancer survivors: a scoping review. Womens Health Rep. 2021; 2 (1): 594–607. https://doi.org/10.1089/whr.2021.0035.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Tramacere F., Lancellotta V., Casà C., et al. Assessment of sexual dysfunction in cervical cancer patients after diﬀerent treatment modality: a systematic review. Medicina. 2022; 58 (9): 1223. https://doi.org/10.3390/medicina58091223.</mixed-citation><mixed-citation xml:lang="en">Tramacere F., Lancellotta V., Casà C., et al. Assessment of sexual dysfunction in cervical cancer patients after diﬀerent treatment modality: a systematic review. Medicina. 2022; 58 (9): 1223. https://doi.org/10.3390/medicina58091223.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Greimel E.R., Kuljanic Vlasic K., Waldenstrom A.C., et al. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer. 2006; 107 (8): 1812–22. https://doi.org/10.1002/cncr.22217.</mixed-citation><mixed-citation xml:lang="en">Greimel E.R., Kuljanic Vlasic K., Waldenstrom A.C., et al. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer. 2006; 107 (8): 1812–22. https://doi.org/10.1002/cncr.22217.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kyei K.A., Yakanu F., Donkor A., et al. Quality of life among cervical cancer patients undergoing radiotherapy. Pan Afr Med J. 2020; 35: 125. https://doi.org/10.11604/pamj.2020.35.125.18245.</mixed-citation><mixed-citation xml:lang="en">Kyei K.A., Yakanu F., Donkor A., et al. Quality of life among cervical cancer patients undergoing radiotherapy. Pan Afr Med J. 2020; 35: 125. https://doi.org/10.11604/pamj.2020.35.125.18245.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Corrêa C.S.L., Leite I.C.G., Andrade A.P.S., et al. Sexual function of women surviving cervical cancer. Arch Gynecol Obstet. 2016; 293 (5): 1053–63. https://doi.org/10.1007/s00404-015-3857-0.</mixed-citation><mixed-citation xml:lang="en">Corrêa C.S.L., Leite I.C.G., Andrade A.P.S., et al. Sexual function of women surviving cervical cancer. Arch Gynecol Obstet. 2016; 293 (5): 1053–63. https://doi.org/10.1007/s00404-015-3857-0.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Hanprasertpong J., Geater A., Jiamset I., et al. Fear of cancer recurrence and its predictors among cervical cancer survivors. J Gynecol Oncol. 2017; 28 (6): e72. https://doi.org/10.3802/jgo.2017.28.e72.</mixed-citation><mixed-citation xml:lang="en">Hanprasertpong J., Geater A., Jiamset I., et al. Fear of cancer recurrence and its predictors among cervical cancer survivors. J Gynecol Oncol. 2017; 28 (6): e72. https://doi.org/10.3802/jgo.2017.28.e72.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Блбулян Т.А., Солопова А.Г., Иванов А.Е., Куркина Е.И. Влияние послеоперационной реабилитации на качество жизни больных раком вульвы. Акушерство, гинекология и репродукция. 2020; 14 (4): 415–25. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.156.</mixed-citation><mixed-citation xml:lang="en">Blbulyan T.A., Solopova A.G., Ivanov A.E., Kurkina E.I. Eﬀect of postoperative rehabilitation on quality of life in patients with vulvar cancer. Obstetrics, Gynecology and Reproduction. 2020; 14 (4): 415–25 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.156.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Z., Shi H. Prognostic Role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis. Disease Markers. 2019; 2019 (1): 6710352. https://doi.org/10.1155/2019/6710352.</mixed-citation><mixed-citation xml:lang="en">Liu Z., Shi H. Prognostic Role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis. Disease Markers. 2019; 2019 (1): 6710352. https://doi.org/10.1155/2019/6710352.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Park S.Y., Bae D.S., Nam J.H., et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007; 110 (12): 2716–25. https://doi.org/10.1002/cncr.23094.</mixed-citation><mixed-citation xml:lang="en">Park S.Y., Bae D.S., Nam J.H., et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007; 110 (12): 2716–25. https://doi.org/10.1002/cncr.23094.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Хохлова С.В., Коломиец Л.А., Кравец О.А. и др. Практические рекомендации по лекарственному лечению рака шейки матки. Злокачественные oпухоли. 2021; 11 (3S2-1): 197–217. https://doi.org/10.18027/2224-5057-2021-11-3s2-13.</mixed-citation><mixed-citation xml:lang="en">Khokhlova S.V., Kolomiets L.A., Kravets O.A., et al. Practical recommendations for the drug treatment of cervical cancer. Malignant Tumours. 2021; 11 (3S2-1): 197–217 (in Russ.). https://doi.org/10.18027/2224-5057-2021-11-3s2-13.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Аксель Е.М., Виноградова Н.Н. Статистика злокачественных новообразований женских репродуктивных органов. Онкогинекология. 2018; 3: 64–78. https://doi.org/10.52313/2227871 0_2018_3_64.</mixed-citation><mixed-citation xml:lang="en">Aksel E.M., Vinogradova N.N. Statistics of malignant neoplasms of female reproductive organs. Oncogynecology. 2018; 3: 64–78 (in Russ.). https://doi.org/10.52313/22278710_2018_3_64.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства труда и социальной защиты РФ от 03.09.2018 № 572н «Об утверждении профессионального стандарта «Специалист по медицинской реабилитации». URL: https://docs.cntd.ru/document/551160092 (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Labor and Social Protection of the RF dated 03.09.2018 No. 572n “On approval of the professional standard ‘Specialist in medical rehabilitation’ ”. Available at: https://docs.cntd.ru/document/551160092 (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Национальная стратегия по борьбе с онкозаболеваниями на долгосрочный период до 2030 года. URL: https://www.nop2030.ru/dokumenty/natsionalnaya-strategiya-po-borbe-sonkozabolevaniyami-na-dolgosrochnyj-period-do-2030-goda/ (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">National strategy against cancer for the long-term period up to 2030. Available at: https://www.nop2030.ru/dokumenty/natsionalnayastrategiya-po-borbe-s-onkozabolevaniyami-na-dolgosrochnyj-perioddo-2030-goda/ (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральный закон от 21.11.2011 № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации». URL: https://www.consultant.ru/document/cons_doc_LAW_121895/ (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Federal Law dated 21.11.2011 No. 323-FZ “On the basics of public health protection in the Russian Federation”. Available at: https://www.consultant.ru/document/cons_doc_LAW_121895/ (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Минздрава России от 29.12.2012 № 1705н «О порядке организации медицинской реабилитации». URL: https://www.consultant.ru/document/cons_doc_LAW_143130/ (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Health of Russia dated 29.12.2012 No. 1705n “On the procedure for organizing medical rehabilitation”. Available at: https://www.consultant.ru/document/cons_doc_LAW_143130/ (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Минздрава России от 23.10.2019 № 878н «Об утверждении порядка организации медицинской реабилитации детей». URL: https://normativ.kontur.ru/document?moduleId=1&amp;documentId=351596&amp;cwi=2170 (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Health of Russia dated 23.10.2019 No. 878n “On approval of the procedure for organizing medical rehabilitation of children”. Available at: https://normativ.kontur.ru/document?moduleId=1&amp;documentId=351596&amp;cwi=2170 (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Минздрава России от 31.07.2020 № 788н «Об утверждении порядка организации медицинской реабилитации взрослых». URL: https://normativ.kontur.ru/document?moduleId=1&amp;documentId=438476 (дата обращения 16.12.2023).</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Health of Russia dated 31.07.2020 No. 788n “On approval of the procedure for organizing medical rehabilitation of adults”. Available at: https://normativ.kontur.ru/document?moduleId=1&amp;documentId=438476 (in Russ.) (accessed 16.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Реестр реабилитационных центров России. Благотворительный фонд «Правмир». URL: https://fondpravmir.ru/reestr/ (дата обращения 17.12.2023).</mixed-citation><mixed-citation xml:lang="en">The register of rehabilitation centers in Russia. Pravmir Charitable Foundation. Available at: https://fondpravmir.ru/reestr/ (in Russ.) (accessed 17.12.2023).</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Weis J., Giesler J.M. Rehabilitation for cancer patients. Recent Results Cancer Res. 2018; 210: 105–22. https://doi.org/10.1007/978-3-319-64310-6_7.</mixed-citation><mixed-citation xml:lang="en">Weis J., Giesler J.M. Rehabilitation for cancer patients. Recent Results Cancer Res. 2018; 210: 105–22. https://doi.org/10.1007/978-3-319-64310-6_7.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Бегович Ё., Солопова А.Г., Хлопкова С.В. и др. Возможности и перспективы эпигенетической реабилитации у пациенток с наружной формой генитального эндометриоза. Врач. 2022; 33 (5): 5–8. https://doi.org/10.29296/25877305-2022-05-01.</mixed-citation><mixed-citation xml:lang="en">Begovich E., Solopova A.G., Khlopkova S.V., et al. Possibilities and prospects of epigenetic rehabilitation in patients with external genital endometriosis. Vrach / The Doctor. 2022; 33 (5): 5–8 (in Russ.). https://doi.org/10.29296/25877305-2022-05-01.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Власина А.Ю., Солопова А.Г., Иванова Е.А., Блбулян Т.А. «Противораковая диета», или принципы рационального питания онкогинекологических больных в период реабилитации. Врач. 2020; 31 (4): 3–7. https://doi.org/10.29296/25877305-2020-04-01.</mixed-citation><mixed-citation xml:lang="en">Vlasina A.Yu., Solopova A.G., Ivanova E.A., Blbulyan T. Anticancer diet, or principles of rational nutrition in gynecological cancer patients during rehabilitation. Vrach / The Doctor. 2020; 31 (4): 3–7 (in Russ.). https://doi.org/10.29296/25877305-2020-04-01.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Хасанов Р.Ш., Озол С.А., Гилязутдинов И.А. и др. Современные принципы реабилитации онкологических больных (обзор литературы). Поволжский онкологический вестник. 2013; 4: 49–55.</mixed-citation><mixed-citation xml:lang="en">Khasanov R.Sh., Ozol S.A., Gilyazutdinov I.A., et al. Modern principles of rehabilitation of oncological patients (literature review). Povolzhsky Oncologichesky Vestnik / Oncology Bulletin of the Volga Region. 2013; 4: 49–55 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Ryan R.F., Shambaugh E.M. Human anatomy as related to tumor formation. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 2001.</mixed-citation><mixed-citation xml:lang="en">Ryan R.F., Shambaugh E.M. Human anatomy as related to tumor formation. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 2001.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Iżycki D., Woźniak K., Iżycka N. Consequences of gynecological cancer in patients and their partners from the sexual and psychological perspective. Prz Menopauzalny. 2016; 15 (2): 112–6. https://doi.org/10.5114/pm.2016.61194.</mixed-citation><mixed-citation xml:lang="en">Iżycki D., Woźniak K., Iżycka N. Consequences of gynecological cancer in patients and their partners from the sexual and psychological perspective. Prz Menopauzalny. 2016; 15 (2): 112–6. https://doi.org/10.5114/pm.2016.61194.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Marin F., Pleşca M., Bordea C., et al. Postoperative surgical complications of lymphadenohysterocolpectomy. J Med Life. 2014; 7 (1): 60–6.</mixed-citation><mixed-citation xml:lang="en">Marin F., Pleşca M., Bordea C., et al. Postoperative surgical complications of lymphadenohysterocolpectomy. J Med Life. 2014; 7 (1): 60–6.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Ткаченко Г.А., Степанова А.М. Психологическая реабилитация онкологических больных: от истоков к современности. Злокачественные опухоли. 2022; 12 (4): 36–40. https://doi.org/10.18027/2224-5057-2022-12-4-36-40.</mixed-citation><mixed-citation xml:lang="en">Tkachenko G.A., Stepanova A.M. Psychological rehabilitation for cancer patients: from the origins to the present. Malignant Tumours. 2022; 12 (4): 36–40 (in Russ.). https://doi.org/10.18027/2224-5057-2022-12-4-36-40.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Идрисова Л.Э., Солопова А.Г., Табакман Ю.Ю. и др. Основные направления психологической реабилитации онкогинекологических больных. Акушерство, гинекология и репродукция. 2017; 10 (4): 94–104. https://doi.org/10.17749/2313-7347.2016.10.4.094-104.</mixed-citation><mixed-citation xml:lang="en">Idrisova L.E., Solopova A.G., Tabakman Yu.Yu., Makatsariya A.D., Surenkov A.A. The main directions of psychological rehabilitation of onсogyneсologic patients. Obstetrics, Gynecology and Reproduction. 2017; 10 (4): 94–104 (in Russ.). https://doi.org/10.17749/2313-7347.2016.10.4.094-104.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Mukherjee O., Rakshit S., Shanmugam G., Sarkar K. Role of chemo therapeutic drugs in immunomodulation of cancer. Curr Res Immunol. 2023; 4: 100068. https://doi.org/10.1016/j.crimmu.2023.100068.</mixed-citation><mixed-citation xml:lang="en">Mukherjee O., Rakshit S., Shanmugam G., Sarkar K. Role of chemotherapeutic drugs in immunomodulation of cancer. Curr Res Immunol. 2023; 4: 100068. https://doi.org/10.1016/j.crimmu.2023.100068.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno-Smith M., Lutgendorf S.K., Sood A.K. Impact of stress on cancer metastasis. Future Oncol. 2010; 6 (12): 1863–81. https://doi.org/10.2217/fon.10.142.</mixed-citation><mixed-citation xml:lang="en">Moreno-Smith M., Lutgendorf S.K., Sood A.K. Impact of stress on cancer metastasis. Future Oncol. 2010; 6 (12): 1863–81. https://doi.org/10.2217/fon.10.142.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Бухтояров О.В., Самарин Д.М. Обоснование необходимости проведения противорецидивной реабилитации больных злокачественными опухолями с психогенным анамнезом. Вестник восстановительной медицины. 2016; 5: 32–6.</mixed-citation><mixed-citation xml:lang="en">Bukhtoyarov O.V., Samarin D.M. Justiﬁcation for the necessity of anti-relapse rehabilitation of cancer patients with psychogenic medical history. Bulletin of Rehabilitation Medicine. 2016; 5: 32–6 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Баллюзек М.Ф., Ионова А.К., Машкова М.В. и др. Организация программ реабилитации онкологических пациентов на основе междисциплинарного подхода. Research’n Practical Medicine Journal. 2018; 5 (4): 91–7. https://doi.org/10.17709/2409-2231-2018-5-4-9.</mixed-citation><mixed-citation xml:lang="en">Ballyuzek M.F., Ionova A.K., Mashkova M.V., et al. Organization of rehabilitation programs for cancer patients based on an interdisciplinary approach. Research and Practical Medicine Journal. 2018; 5 (4): 91–7 (in Russ.). https://doi.org/10.17709/2409-2231-2018-5-4-9.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Liu L., He J., et al. Analysis of the eﬀectiveness of the application of pelvic ﬂoor rehabilitation exercise and the factors inﬂuencing its self-eﬃcacy in postoperative patients with cervical cancer. Front Oncol. 2023; 13: 1118794. https://doi.org/10.3389/fonc.2023.1118794.</mixed-citation><mixed-citation xml:lang="en">Li X., Liu L., He J., et al. Analysis of the eﬀectiveness of the application of pelvic ﬂoor rehabilitation exercise and the factors inﬂuencing its self-eﬃcacy in postoperative patients with cervical cancer. Front Oncol. 2023; 13: 1118794. https://doi.org/10.3389/fonc.2023.1118794.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Zhou C.K., Song J., et al. Curative eﬃcacy of low frequency electrical stimulation in preventing urinary retention after cervical cancer operation. World J Surg Oncol. 2019; 17: 141. https://doi.org/10.1186/s12957-019-1689-2.</mixed-citation><mixed-citation xml:lang="en">Li H., Zhou C.K., Song J., et al. Curative eﬃcacy of low frequency electrical stimulation in preventing urinary retention after cervical cancer operation. World J Surg Oncol. 2019; 17: 141. https://doi.org/10.1186/s12957-019-1689-2.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Cullen K., Fergus K., DasGupta T., et al. Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer. Support Care Cancer. 2013; 21 (7): 1911–7. https://doi.org/10.1007/s00520-013-1726-6.</mixed-citation><mixed-citation xml:lang="en">Cullen K., Fergus K., DasGupta T., et al. Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer. Support Care Cancer. 2013; 21 (7): 1911–7. https://doi.org/10.1007/s00520-013-1726-6.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Monteiro M.G.C.T., de Morais Gouveia G.P. Physiotherapy in the management of gynecological cancer patient: a systematic review. J Bodyw Mov Ther. 2021; 28: 354–61. https://doi.org/10.1016/j.jbmt.2021.06.027.</mixed-citation><mixed-citation xml:lang="en">Monteiro M.G.C.T., de Morais Gouveia G.P. Physiotherapy in the management of gynecological cancer patient: a systematic review. J Bodyw Mov Ther. 2021; 28: 354–61. https://doi.org/10.1016/j.jbmt.2021.06.027.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Grassi L., Spiegel D., Riba M. Advancing psychosocial care in cancer patients. F1000Res. 2017; 6: 2083. https://doi.org/10.12688/f1000research.11902.1.</mixed-citation><mixed-citation xml:lang="en">Grassi L., Spiegel D., Riba M. Advancing psychosocial care in cancer patients. F1000Res. 2017; 6: 2083. https://doi.org/10.12688/f1000research.11902.1.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Feng W. Cancer-related psychosocial challenges. Gen Psychiatr. 2022; 35 (5): e100871. https://doi.org/10.1136/gpsych-2022-100871.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Feng W. Cancer-related psychosocial challenges. Gen Psychiatr. 2022; 35 (5): e100871. https://doi.org/10.1136/gpsych-2022-100871.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Естенкова М.Г., Елизаров А.Н. К вопросу санаторно-курортного лечения больных, имеющих онкологические заболевания. Физиотерапия, бальнеология и реабилитация. 2013; 6: 54–5.</mixed-citation><mixed-citation xml:lang="en">Estenkova M.G., Elizarov A.N. About the spa and resort-based treatment of the patients with oncological diseases. Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2013; 6: 54–5 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Meixner E., Sandrini E., Hoeltgen L., et al. Return to work, fatigue and cancer rehabilitation after curative radiotherapy and radiochemotherapy for pelvic gynecologic cancer. Cancers. 2022; 14 (9): 2330. https://doi.org/10.3390/cancers14092330.</mixed-citation><mixed-citation xml:lang="en">Meixner E., Sandrini E., Hoeltgen L., et al. Return to work, fatigue and cancer rehabilitation after curative radiotherapy and radiochemotherapy for pelvic gynecologic cancer. Cancers. 2022; 14 (9): 2330. https://doi.org/10.3390/cancers14092330.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Liang M.I., Simons J.L., Herbey I.I., et al. Navigating job and cancer demands during treatment: a qualitative study of ovarian cancer patients. Gynecol Oncol. 2022; 166 (3): 481–6. https://doi.org/10.1016/j.ygyno.2022.07.021.</mixed-citation><mixed-citation xml:lang="en">Liang M.I., Simons J.L., Herbey I.I., et al. Navigating job and cancer demands during treatment: a qualitative study of ovarian cancer patients. Gynecol Oncol. 2022; 166 (3): 481–6. https://doi.org/10.1016/j.ygyno.2022.07.021.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamura K., Masuyama H., Ida N., et al. Radical hysterectomy plus concurrent chemoradiation/radiation therapy is negatively associated with return to work in patients with cervical cancer. Int J Gynecol Cancer. 2017; 27: 117–22. https://doi.org/10.1097/igc.0000000000000840.</mixed-citation><mixed-citation xml:lang="en">Nakamura K., Masuyama H., Ida N., et al. Radical hysterectomy plus concurrent chemoradiation/radiation therapy is negatively associated with return to work in patients with cervical cancer. Int J Gynecol Cancer. 2017; 27: 117–22. https://doi.org/10.1097/igc.0000000000000840.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Wu X., Liu Y., Zhu D., et al. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity lymphedema after operation of gynecologic cancer. Asian J Surg. 2021; 44 (1): 111–5. https://doi.org/10.1016/j.asjsur.2020.03.022.</mixed-citation><mixed-citation xml:lang="en">Wu X., Liu Y., Zhu D., et al. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity lymphedema after operation of gynecologic cancer. Asian J Surg. 2021; 44 (1): 111–5. https://doi.org/10.1016/j.asjsur.2020.03.022.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrell B.R., Smith S.L., Ervin K.S., et al. A qualitative analysis of social concerns of women with ovarian cancer. Psychooncology. 2003; 12 (7): 647–63. https://doi.org/10.1002/pon.681.</mixed-citation><mixed-citation xml:lang="en">Ferrell B.R., Smith S.L., Ervin K.S., et al. A qualitative analysis of social concerns of women with ovarian cancer. Psychooncology. 2003; 12 (7): 647–63. https://doi.org/10.1002/pon.681.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Власина А.Ю., Идрисова Л.Э., Солопова А.Г. и др. Реабилитация онкогинекологических больных после противоопухолевой терапии: пути решения. Акушерство, гинекология и репродукция. 2020; 14 (1): 44–55. https://doi.org/10.17749/2313-7347.2020.14.1.44-55.</mixed-citation><mixed-citation xml:lang="en">Vlasina A.V., Idrisova L.E., Solopova A.G., et al. Rehabilitation of oncogynecological patients after antitumor therapy: ways of solution. Obstetrics, Gynecology and Reproduction. 2020; 14 (1): 44–55 (in Russ.). https://doi.org/10.17749/2313-7347.2020.14.1.44-55.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang C., Sheng Y., Sun X., Wang Y. New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions. Cancer Metastasis Rev. 2023; 42 (3): 891–925. https://doi.org/10.1007/s10555-023-10113-2.</mixed-citation><mixed-citation xml:lang="en">Zhang C., Sheng Y., Sun X., Wang Y. New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions. Cancer Metastasis Rev. 2023; 42 (3): 891–925. https://doi.org/10.1007/s10555-023-10113-2.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
